glp-1 oral reviews Novo applies to FDA for cardio label expansion of Rybelsus Oral GLP-1 Medication Helps Patients

The addition of lixisenatide to standard therapy did not significantly alter the rates of CV events or hospitalizations in high-risk patients, although it did result in modest but significant reductions in A1c, weight, and systolic BP compared to standard therapy

The FDA stated it intends to restrict GLP-1 active pharmaceutical ingredients used in non-FDA-approved compounded drugs that are mass-marketed as alternatives, and it named Hims & Hers directly

Regulators are responding to this expansion with increased oversight

What about Ozempic personality

68,69 Adverse effects of GLP-1RA include gastrointestinal side effects (nausea, vomiting, diarrhea), increased heart rate, and injection site reactions